Clinical Trials Directory

Trials / Completed

CompletedNCT03452956

Cognitive Impairement In Frontotemporal Dementia

Status
Completed
Phase
Study type
Observational
Enrollment
997 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is hoped the information gathered in this study will help lead to better diagnostics and future treatments.

Detailed description

Comparative and longitudinal studies reveal clinical differences between subgroups of patients with frontotemporal dementia (FTD), including Progressive Non-fluent Aphasia (PNFA), Semantic Dementia (SD), patients with a disorder of social comportment and personality (SOC), and non-aphasic patients with executive dysfunction (EXEC). MRI studies of cortical atrophy and fMRI studies show correlated neural defects in FTD subgroups. The investigators will obtain converging evidence from multiple sources to test hypotheses about the neural basis for cognitive functions such as semantic memory, grammatical processing, and social functioning in these FTD subgroups, while improving clinical care for these patients. Recent studies have linked progressive supra nuclear palsy (PSP) and multiple systems atrophy (MSA) to FTD. The investigators will obtain comparable neuropsychological and biomarker data in order to compare these patient groups.

Conditions

Interventions

TypeNameDescription
OTHERNone-Observation OnlyNo intervention-this is an observational study

Timeline

Start date
2003-07-01
Primary completion
2020-07-15
Completion
2020-07-15
First posted
2018-03-02
Last updated
2020-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03452956. Inclusion in this directory is not an endorsement.